OTCMKTS:SKVI Skinvisible (SKVI) Stock Price, News & Analysis → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free SKVI Stock Alerts $0.49 +0.07 (+16.67%) (As of 02:57 PM ET) Add Compare Share Share Today's Range$0.49▼$0.4950-Day Range$0.06▼$0.5152-Week Range$0.06▼$0.51Volume2,000 shsAverage Volume5,984 shsMarket Capitalization$2.22 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get Skinvisible alerts: Email Address Ad Banyan Hill PublishingA New Generation of Billionaires Is About to Be CreatedOn June 30, AI will hit a tipping-point… $15.7 trillion of wealth is at stake. As many as 800 million jobs are caught in AI’s crosshairs…Click here for details. About SkinvisibleSkinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. It also develops and licenses prescription and over-the-counter products to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.Read More SKVI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SKVI Stock News HeadlinesMay 29, 2024 | finanznachrichten.deSkinvisible, Inc.: Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal TreatmentMay 29, 2024 | finance.yahoo.comSkinvisible Submits Innovative Obesity Patent for Advanced Transdermal TreatmentMay 15, 2024 | seekingalpha.comZHUD Zhuding International LimitedFebruary 14, 2024 | finanznachrichten.deSkinvisible, Inc.: Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons SyndromeFebruary 14, 2024 | finance.yahoo.comSkinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons SyndromeMarch 2, 2023 | finance.yahoo.comSkinvisible, Inc. (SKVI) Stock Historical Prices & Data - Yahoo FinanceSeptember 8, 2022 | reuters.comSKVI.PK - Skinvisible Inc | Stock Price & Latest News | ReutersJune 6, 2022 | finanznachrichten.deSkinvisible Inc: Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New DrugSee More Headlines Receive SKVI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Skinvisible and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today6/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:SKVI CUSIPN/A CIK1085277 Webwww.skinvisible.com Phone(702) 433-7154Fax702-433-7192Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,380,000.00 Net Margins-5,790.00% Pretax Margin-5,785.00% Return on EquityN/A Return on Assets-663.94% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$20,000.00 Price / Sales95.34 Cash FlowN/A Price / Cash FlowN/A Book Value($1.99) per share Price / Book-0.21Miscellaneous Outstanding Shares4,540,000Free Float2,134,000Market Cap$1.91 million OptionableNot Optionable Beta-0.30 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Terry H. Howlett (Age 76)President, CEO, CFO, Principal Accounting Officer & Director Comp: $180kMs. Doreen McMorran (Age 62)Head of Business Development Key CompetitorsBright Minds BiosciencesNASDAQ:DRUGAzitraNYSEAMERICAN:AZTRBiofronteraNASDAQ:BFRIYumanity TherapeuticsNASDAQ:YMTXSonnet BioTherapeuticsNASDAQ:SONNView All Competitors SKVI Stock Analysis - Frequently Asked Questions How have SKVI shares performed in 2024? Skinvisible's stock was trading at $0.0838 at the beginning of 2024. Since then, SKVI shares have increased by 401.5% and is now trading at $0.42. View the best growth stocks for 2024 here. How were Skinvisible's earnings last quarter? Skinvisible, Inc. (OTCMKTS:SKVI) announced its quarterly earnings data on Tuesday, April, 16th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.01 million for the quarter. What other stocks do shareholders of Skinvisible own? Based on aggregate information from My MarketBeat watchlists, some companies that other Skinvisible investors own include HEXO (HEXO), BTCS (BTCS), Bunker Hill Mining (BHLL), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY), Aeolus Pharmaceuticals (AOLS), Akari Therapeutics (AKTX), Adicet Bio (ACET) and Aurora Cannabis (ACB). How do I buy shares of Skinvisible? Shares of SKVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SKVI) was last updated on 6/6/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skinvisible, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skinvisible With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.